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Abstract: Early identification/diagnosis of diabetes and frequent monitoring of hyperglycemia reduces
hospitalizations and diabetes-related complications. The present study investigated the proportion of
older adults coded with diabetes or newly diagnosed during their admissions and assessed discharge
summary content for diabetes-related information. The study used electronic data on 4796 individuals
aged ≥60 years admitted through the emergency department (ED) of a public hospital from 2017 to
2018 extracted using International Classification of Diseases, Tenth Revision, Clinical Modification
(ICD-10-CM code). The proportion of admitted patients who were diagnosed with diabetes over
a one-year period, proportion with glycated hemoglobin A1c (HbA1c) and random blood glucose
(RBG) test performed during their stay, length of stay, discharge summary information and the
factors associated with elevated HbA1c (>7%/53 mmol/mol) were investigated. In total, 8.6% of ED
presentations to the hospital were coded with diabetes, excluding gestational consisting of 879 patients
(449 males, 430 females) aged ≥ 60 years (74.6 ± 8.9 years). In total, 98% had type 2 diabetes (n = 863),
53% were Australian-born (n = 467), and the mean body mass index (BMI, 31 ± 7 kg/m2; n = 499,
56.8%), RBG (9.8 ± 5.2 mmol/L; n = 824, 93.7%) and HbA1c (8.0 ± 2.0%; n = 137, 15.6%) and length
of stay (6.7 ± 25.4 days) were similar between gender, age, and nationality (p > 0.05). Three coded
patients (0.3%) were newly diagnosed during the admission. In total, 86% had elevated HbA1c,
but this was recorded in 20% of discharge summaries. Patients who are on a combination therapy
(adjusted odds ratio 23%, 95% confidence intervals: 7%/38%), those on SGLT2 Inhibitors (aOR, 14%:
2%/26%) or had a change in medication (aOR, 40%: 22%/59%) had lower odds of having elevated
HbA1c during admission. The low diagnosis rate of diabetes and the lack of clinical assessment of
HbA1c in older adults admitted through the ED of a South Western Sydney public hospital suggest
that many patients with diabetes either remain undiagnosed even during admission and/or are going
to the ED with unknown diabetes that is unidentified with current practices. The clinically important
HbA1c results were only infrequently communicated with general practitioners (GPs).
Keywords: type 2 diabetes; opportunistic testing; blood glucose; hyperglycemia; emergency department;
South Western Sydney Local Health District; public health; hospital admission; Hemoglobin A1c;
Discharge summary
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1. Introduction
Diabetes is a significant health problem globally [1], in Australia [2] and in the South Western
Sydney (SWS) region [3], resulting in significant morbidity and mortality [4]. In 2017, there were
approximately 1.3 million adults living in Australia with known diabetes, with the number reaching
well over 1.7 million including those with undiagnosed diabetes [2]. In SWS, the number of people
with diabetes (all types) has increased by over 158% since 2000 [3] exceeding that of the state and
national averages [3,5]. The rising obesity, the ageing population, dietary changes, and sedentary
lifestyles [6,7] likely drive this increase. According to a recent monograph, approximately 60.9% of
people with diabetes in SWS were aged 60 years and over [8]. Evidence indicates that diabetes in older
adults is linked to higher mortality, reduced functional status, and increased risk of hospitalization [9].
Older adults with diabetes are also at substantial risk for both acute and chronic microvascular and
cardiovascular complications of the disease [10]. However, under detection remains a major barrier
to prevention of diabetes and associated complications particularly in older individuals, who are
considered a high-risk group for diabetes [8,11], with more than a third of people with diabetes being
undiagnosed on presentation to hospital [12].
Early detection of diabetes is recommended because the duration of hyperglycemia is a predictor
of adverse outcomes and there are effective interventions to reduce the risk of complications [13,14].
Although, the recommended laboratory techniques and protocols for diabetes testing are fasting plasma
glucose (FPG) level or a two-hour oral glucose tolerance test (OGTT), these are not suitable for acutely
ill patients in an emergency department (ED) setting [13]. The World Health Organization (WHO)
and the American Diabetes Association recommends that diagnosis and monitoring of people with
diabetes can be made with glycated hemoglobin A1c (HbA1c) alone (≥6.5% or 48 mmol/mol on two
separate occasions [13,15]), but the test is influenced by the lifespan of the red blood cell, generating
multiple false positive and false negative results compared with the OGTT. Thus, it was suggested that
HbA1c in combination with blood glucose testing should be used in diabetes screening [16].
There are many individuals with risk factors for diabetes, who do not have access to primary care
and present to the ED seeking care for unrelated illnesses. The ED also provides medical care to people
with little or no access to screening and preventive interventions; therefore, initiating a screening
intervention in the ED may improve the health of this vulnerable population. The ED of Campbelltown
hospital of SWS serves approximately 283,743 residents across the district (ABS Census 2016) [17]
and during a visit to the ED, blood glucose levels are also regularly tested particularly in high-risk
individuals, making the department a potentially valuable location to conduct opportunistic screening
for diabetes [12,18–20]. Given the large number of presentations at the ED, missed opportunities
for diabetes screening could be common [21] and patients who are newly diagnosed with diabetes
from the screening test may not have been closely monitored [22]. The aim of this study was to
determine the proportion of patients aged ≥ 60 years admitted through the ED coded with diabetes or
newly diagnosed during their admission over a one-year period. Furthermore, the study sought to
determine the sort of notes and follow-up requests made in the patients’ discharge referrals regarding
the management of diabetes.
2. Materials and Methods
2.1. Study Setting and Population
This retrospective cohort study reviewed the clinical data of patients admitted through the ED
of a public Hospital in SWS. A list of all admitted patients that were coded with diabetes (excluding
gestational diabetes mellitus), between 1 July 2017 and 30 June 2018, was provided by the clinical
information department (CID) at the hospital. The electronic file contained some of the required
demographic data (age, sex, country of birth) for each patient along with admission details (e.g., dates
of presentation and discharge, reason for presentation, length of stay [date of discharge minus date
of admission] see Table 1), coded diabetes complications (e.g., diabetic nephropathy or background
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retinopathy), and co-morbidities (hypertension and ischemic heart disease). The remaining parameters
including glycated hemoglobin (HbA1c), discharge summary notes and requests for follow-up
were extracted manually from each selected patient’s electronic medical record (Cerner Millennium,
Cerner Corporation. North Sydney, NSW, Australia). Where available, glucose results from laboratory
and point of care blood glucose testing obtained from the ED using a Roche Cobas 6000 chemistry
analyzer (Roche Diagnostics, Indianapolis, IN, USA) and an Abbot I-Stat device with CHEM 8+
cartridges (Abbott point of Care Inc., Princeton, NJ, USA), respectively, were also extracted from patient
record. Obesity as coded in the ICD-10-AM was provided by the department and was cross-checked
manually in the electronic records of individual patients. Where BMI was available in the patient
records, this was preferred, and the classification of obesity was BMI ≥ 30 kg/m2.
2.2. Ethics
The study was considered as a quality assurance activity by the hospital Quality and Safety Office,
under the framework overseen by the South Western Sydney Local Health District Human Research
Ethics Committee (#QA18/021).
2.3. Selection Protocol
The extraction included 5100 electronic admission records of patients who visited the ED within
the study period and were coded with diabetes. Duplicate admissions were identified and removed,
and the remaining admissions were randomized using an Excel spreadsheet function and manual
selection. It was not feasible to go through all the admitted patient electronic medical records, and so
randomization was used to select a representative sample from a pool of patient records (all ages).
Only the medical records of patients aged ≥ 60 years were reviewed and included in this study. This age
group was selected because, in Australia, prevalence in this age group is substantially higher than
the average for all age groups [23]. In order to avoid data clustering, only one admission was kept
for patients who were admitted more than once. In general, the most recent admission was kept.
However, if a patient had an admission with information related to diabetes in their clinical notes or
follow-up requests in their discharge referral, or if the admission included a HbA1c measurement,
this was kept in preference to any other admission. No new cases of diabetes were excluded due to
this selection process.
2.4. ED Outcome Variables
Using an ethics approved data collection form, one researcher (FEW) viewed and systematically
retrieved required information from the medical record of the selected admissions. To ensure reliability
of the data set, a second reviewer (ULO) reviewed the electronic medical records of the first 35 patients
and the data extracted was the same as that extracted by the first reviewer. The variables that were
extracted included demographic characteristics, presentation details, reported weight, BMI, medical
history, vital signs, medications, reason for presentation, time of presentation, mode of transport
to ED, transfer to other facilities on discharge, random serum glucose, glycosylated haemoglobin
(HbA1c), blood pressure levels, diabetes type, diabetes comorbidities including presence and absence
of hypertension, and complications including death. Notes in the discharge summary including request
for follow up, referrals, and documentation of blood glucose levels were also examined. HbA1c of 7%
or lower or laboratory blood glucose ≤ 12.0 mmol/L was considered target for glycaemic control in the
admitted patients in this hospital.
2.5. Statistical Analysis
Notes and requests for follow-ups were categorized and all data was entered into a secure Excel
spreadsheet (Microsoft Inc. Redmond, WA, USA) accessible to only the researchers. All statistical
analysis was conducted using IBM SPSS Statistics version 25 (IBM Inc. Chicago, IL, USA). The level of
statistical significance was set at 5%. Normality distribution assessment confirmed that all assumptions
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met the parametric text. A chi-square test for discrete variables and one-way analysis of variance for
continuous variables were utilized to assess the differences between variables or groups. General
linear model for multivariable analysis determined the association of age, gender and ethnicity with
other variables and determined the factors associated with elevated HbA1c. Results were presented
descriptively as mean (standard deviation), counts and/or proportions and adjusted odds ratio (aOR)
for associations between variables, where necessary.
3. Results
Figure 1 presents the flow diagram of the patients’ records and method of selection. Of the
55,968 ED presentations to the hospital during the one-year study period, there were 4796 unique
people admitted and coded with diabetes excluding gestational, resulting in a prevalence of 8.6%
among patients aged 65 ± 17 years (mean ± SD). The final selection resulted in the inclusion of 879
(18.3%) hospital admissions of people (449 males, 51.1%, and 430, 48.9% females) aged ≥ 60 years
(mean age of 74.6 ± 8.9 years), in this study.
Figure 1. Flow chart for method for admission selected for inclusion in the study.
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3.1. Characteristics of the Patients
Table 1 presents the demographic characteristics of the patients in this study including their
medication types. The majority of the admitted patients in this study hospital were Australian-born
(n = 467, 53.1%, including 23 (2.6%) Aboriginal patients) and European-born (n = 408, 46.4%), who
were also significantly older (77 ± 8 years vs 74 ± 9 years, p < 0.0001) than the Australian-born patients.
Figure 2 presents the breakdown of the participant’s country of birth in this study.
Figure 2. Distribution by country of birth of patients with diabetes admitted through the
emergency department.
There were three newly diagnosed patients (0.3%) with diabetes during the study period and
their ages were 62, 65, and 85 years. BMI was recorded in 56.8% of the patients (n = 499, mean BMI
was 31 ± 7 kg/m2) and 78.4% were either overweight or obese. There were significantly more people
within the 70–79 years (84.6%, n = 143/169) and 60–69 years (83.8%, n = 145/173) age groups who were
either overweight or obese compared to those aged >80years (65.6%, n = 103/157; p = 0.0005).
The mean length of stay during admission was 6.7 ± 25.4 days, with 63% staying longer than one
day: this was not dependent on gender, age, ethnicity, HbA1c or RBG levels of the patients. Among
this age group, the reasons for presentation to the ED were primarily due to chest pain/abdominal pain
(17.6%) and shortness of breath (10.4%) (Figure 3), but for the newly diagnosed patients, hyperglycemia
was the main presenting symptom in two of the three patients.
Figure 3. Reasons for presentation to the emergency department among admitted patients with diabetes.
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Regarding diabetes medications, 78.6% (n = 691) of the patients with diabetes were taking at
least one medication during the period of this study, and 35.3% (n = 310) were taking multiple (>2)
medications. Approximately one-half of the patients (n = 444) had at least one diabetes-related
complication and similar proportion had at least one diabetes-related comorbidity (49.5%, n = 435)
during admission. Figure 4 shows the breakdown of the complications and comorbidities experienced
by the patients during admission and the rate of assessment of glucose level using HbA1c test in
these patients.
Figure 4. Number of patients, admission rates and rate of glycated hemoglobin A1c (HbA1c) assessment,
within patients with diabetes-related complications and comorbidities.
3.2. Glycaemic Monitoring of People with Diabetes
One hundred and thirty-seven patients (15.6%) had at least one HbA1c test during admission,
including the 3 newly diagnosed individuals, and this was similar between T1DM and T2DM (21.0%
vs. 15.4%, p = 0.45) patients. Compared to this, significantly more patients had RBG (n = 857, 97.5%,
p < 0.0001) which was also similar between T1DM and T2DM 100% vs. 97.5%, p = 0.75). The mean
values of laboratory and finger prick blood glucose testing were similar (9.8 ± 5.2 mmol/L, versus
10.1 ± 4.7 mmol/L, p = 0.146) among admitted patients with diabetes. The proportion of patients
aged 60 years and over, who had HbA1c < 7% during admission were significantly fewer than those
who had target RBG (≤11.0 mmol/L) (5.9% vs 71.8% for laboratory or 54.0% for finger prick glucose,
p < 0.05). Among the patients with a glucose level of ≤11.0 mmol/L, who also had an HbA1c test
completed during admission (n = 75), forty-three percent (n = 49) had a HbA1c above 7%, indicating
the differences between both tests for identifying patients with abnormal glycaemia.
Age and country of birth were associated with the patients’ mode of transportation to ED and
of complications, diabetes-related foot ulcer was predominant among the admitted patients who
were aged 60–69 years (4.3%) compared to those who were aged 70–79 years (1.3%) and those aged
≥ 80 years and over (0.4%, p = 0.002). On discharge from the ED, 17.1% (n = 150) of the patients in this
study were transferred to the critical care unit and the rest went to the wards (729, 82.9%).
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Table 1. Characteristics of patients with diabetes attending the emergency department (ED) between
2017 and 2018 (number n = 879, except where indicated).
Parameter Frequency/Values
Age at admission, (mean ± Standard deviation SD) years 74.6 ± 8.9
Gender, (n, %)
Male 449 (51.1)
Country of birth, n (%)
Australia 467 (53.1)
Overseas 408 (46.4)
Diabetes type, n (%)
Type 1 diabetes 12 (1.4)
Type 2 diabetes 863 (98.2)
Other types 4 (0.4)
Body mass index (mean ± SD), kg/m2 30.5 ± 7.0
Obesity (≥30 kg/m2) 238 (47.7)
Weight (mean ± SD), kg (n = 522) 83.8 (20.1)
Blood glucose testing
HbA1c done, n (%) 137 (15.6)
Mean ± SD %, mmol/mol 8.0 ± 1.9, 63.5 ± 20.8
HbA1c > 7%, n (%) α 85 (62.0)
Random Blood Glucose (RBG) done, n (%) (Laboratory RBG/finger prick RBG) 824 (93.7)/633(70.0)
Mean ±SD lab RBG/finger prick RBG, in mmol/L 9.8 ± 5.2/10.1 ± 4.7
Laboratory, finger prick RBG > 11 mmol/L, n (%) 193 (23.4), 158 (25.0)
Blood pressure (mean ± SD), mmHg
Systolic 140 (26)
Diastolic 76 (13)
BP >130/80, n (%) 576 (65.5)
Length of stay, (mean ± SD) days 6.7 ± 25.4, range 0–370
>1 day 556 (63.3%)
Arrival by emergency medical service (ambulance) 558 (63.5%)
From nursing home or long-term care facility, % 94 (10.7)
Transfer to critical care unit 150 (17.1%)
Diabetes management, n (%) o
Monotherapy (one treatment) 300 (34.1)
Combination therapy (>one treatment) 391 (44.5)
No medication 188 (21.4)
Medication type
Insulin alone 241 (27.4)
Metformin alone 489 (55.6)
Insulin and metformin 103 (11.7)
Other oral hypoglycaemic agents 349 (39.7)
Sulfonylureas 201 (22.9)
DPP4 inhibitors 182 (20.7)
SGLT2 inhibitors 64 (7.3)
Source of referral to ED
Self/family/friends 608 (69.2)
Medical practitioner (General Practitioner GP/Dentist) 127 (14.4)
Other facilities 144 (16.4)
Mode of transport to ED
Ambulance 564 (64.2)
Private car/others 261 (29.7)
No transport 54 (6.1)
Abbreviations: HbA1c, glycated hemoglobin; DPP4, dipeptidyl peptidase-4; SGLT2, sodium glucose co-transporter
protein 2; EMS, emergency medical service. α Australian diabetes society recommended guideline [24].
o All medications recorded in the case history and discharge referral were recorded for each patient where possible.
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3.3. Discharge Summaries
For eight hundred and thirty-seven patients (95.2%), there were notes on their discharge summaries
regarding diabetes and for the remaining 42 patients (4.8%), there was no note. Table 2 presents the
analysis of the notes in the discharge summaries. One in five discharge summaries contained some
notes on the participant’s diabetes, including changes to diabetes medication and abnormal blood
glucose levels. For the patients with elevated HbA1c, 20% had a note regarding the test result in their
discharge summaries, compared to 5.8% (p = 0.015) of the patients with HbA1c ≤ 7% (n = 3) with such
notes in their discharge summaries.
Table 2. Summary of notes and requests for ongoing care in discharge referrals. Percentages included
only those with discharge referral in the medical record for the admission (n = 837, 95.2%).
Parameter Frequency (%)
Any diabetes-related note 171 (20.4)
Changes to diabetic medications during admission noted 109 (13.0)
Abnormal blood glucose result noted 104 (12.4)
Request for GP and/or patient to monitor blood sugar level 68 (8.1)
Request for GP to refer patient for HbA1c test 6 (0.7)
Request for GP to follow-up HbA1c result 1 (0.1)
Request for GP to review patient’s diabetes medications 38 (4.5)
Consultation by diabetes educator during admission noted 21 (2.5)
Current HbA1c test result noted 20 (2.4)
Previous HbA1c test result noted 8 (1.0)
Changes to management of diabetes during admission noted 7 (0.8)
Ketosis during admission noted 3 (0.4)
Request for patient to follow-up with endocrinologist noted 53 (6.3)
Abbreviation: HbA1c, glycated hemoglobin.
Further analysis on the type of patients that make up the top note requests (Table 2) showed that
younger patients (4.2% for 60-69 years) were more likely to have this noted in their DS, compared to
older patients (2.4% and 0.8% for 70–79 years, and ≥80 years old, respectively; p = 0.03). Those with
elevated HbA1c during admission (20.5%), were also more likely to have this noted in their DS than
those with HbA1c ≤ 7% (6.0%, p = 0.003). Having a diabetes-related note in the DS was more likely to
occur in patients on multiple diabetes medications (33.7%) compared to those on either two (17.7%) or
a single medication (16.8%, p < 0.0005) for diabetes management. Patients on SGLT2 inhibitors (41.9%
vs. 18.7%, p < 0.0005), those on DPP4 inhibitors (30.6 vs. 17.7%, p < 0.0005), sulfonylureas (32.1 vs.
16.9%, p = 0.0001) and insulin (44.7% vs. 11.0%, p < 0.0005), were more likely to have diabetes-related
information in their DS, compared to those who were not taking any of the medications (p < 0.0005,
for all comparison) during admission. All patients (100%) with a change in diabetes medication had
a diabetes-related note in their DS compared to 8.5% of those that had no change in medication during
admission (p < 0.0005). Those who were referred to a diabetes educator (100% vs 18.4%, p < 0.0005) or
to a specialist (27.1% vs. 11.9%, p < 0.0005) and those with poor glycaemic control (71.1% vs. 36.0%,
p < 0.0005), during admission were also more likely to have diabetes-related notes in the DS.
3.4. Factors Associated with Elevated HbA1c
The odds of having elevated HbA1c during admission was reduced by 14% (95% CI of aOR
2%–26%) and by 23% (95%CI of aOR: 7%–38%) in patients who were taking SGLT2 Inhibitors or
a combination therapy consisting of insulin and metformin, respectively, during admission. A change
in diabetes medication of the patients was also associated with 40% (95% CI of adjusted odds ratio
22%–59%) reduction in the odds of having elevated HbA1c, during admission. There was no significant
association between the demographic variables and having elevated HbA1c in this study.
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4. Discussion
The main findings of this study were the low diagnosis rate of diabetes (0.3%) in the admitted
patients coded with diabetes, over a one-year period, the low communication rate between the hospitals
and the general providers, and the very low uptake of glucose monitoring using HbA1c test, even in
those with diabetes-related complications/comorbidities, despite the high prevalence of diabetes in this
age group [8] and in the SWS region [25]. A higher prevalence of diabetes (38.4% vs. 8.6%) was found
in another public hospital ED in Western Sydney, a neighboring district with a similar high diabetes
prevalence, and 32.2% of those with diabetes were previously undiagnosed diabetes of diabetes (32.2%),
after 6 months of testing for diabetes in adults using HbA1c, irrespective of their presenting signs [12].
The proportion of newly diagnosed individuals with diabetes increased by 7-fold (from 0.3% to 2.2%);
considering only the individuals with HbA1c test done during the admission (n = 3/137), however,
this was still lower than in the previous study [12] and the 15% population prevalence of diabetes in
those aged ≥ 60 years [8]. Since this region and Western Sydney are the hotspots for diabetes in the
country [25], a larger than average number of undiagnosed individuals with diabetes were expected to
be living in these areas. The percentage of individuals with diabetes in this study was significantly
lower than the expected proportion in the general population, which indicates that there must be
people either going to the ED with unknown diabetes that is unidentified with current practices, and/or
that a significant proportion of the individuals with diabetes remain undiagnosed throughout their
admission. This may be due to the low uptake of HbA1c testing during admission and thus, are prone
to having more complications due to the hyperglycaemic duration [13,26]. It appears that this SWS
public hospital may not be delivering this much-needed service, even in such high-risk age group [8].
This is despite the various government initiatives encouraging routine screening and monitoring of
diabetes in the Australian public hospitals, particularly at the ED, using HbA1c test [27,28], and the
evidence favouring screening for diabetes using HbA1c over other screening techniques including
Oral Glucose Tolerance testing (OGTT) [27]. The potential medico-legal liability of diagnosing without
ensuring follow-up occurs, crowding and staff constraints of the ED and wards, and reluctance of
doctors to treat hyperglycemia for fear of causing hypoglycemia are possible barriers to effectively
diagnose and prevent diabetes-related complications [29,30]. Initiating an automatic request procedure
for HbA1c testing particularly in high-risk groups (older adults and Aboriginals) admitted through the
ED is needed to reduce the burden of diabetes across the district.
The fact that the important HbA1c test result or request related to the patient’s diabetes was
made only in one of five admitted patient records indicate the need to measure and improve discharge
summary quality in this hospital. Information in the discharge summary helps the general practitioner
in decision making including altering a patient’s management plan, and/or referring to specialist
(endocrinologist, dietician or diabetes educator). In this study, patients aged between 60 and 69 years
referred to a diabetes specialist for inadequate glycaemic control were more likely to have these recorded
in their discharge summary notes. For example, in all three patients diagnosed with diabetes during
their admission, this was in their discharge summaries, along with newly prescribed medications.
Ideally, a request for follow-up should be found in the discharge referral of patients diagnosed with
diabetes or those found to have blood glucose or HbA1c results suggestive of diabetes, and absence of
such records may compromise the ability for treatment and prevention of complications [18,29,30],
which may result in a higher risk of re-admission [31].
Although, HbA1c has been used widely to assess glycaemic control in patients with diabetes [32],
the test was rarely used in this hospital in people with both T1DM and T2DM. Even during the
admission, not many patients with diabetes seem to have completed HbA1c test and no notes in the
patients charts to indicate why the test was not completed. Among the patients who had HbA1c
test done, the readings were elevated in 77% of the cases but the odds were reduced in those who
were taking a combination therapy (insulin plus metformin), or the SGLT2 inhibitors. Studies have
shown that HbA1c results correlate with diabetic microvascular disease such that reduction in HbA1c
reduces the risk of complications in people with diabetes [33]. Also, the fact that only a few people
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were identified as having T1DM in this age group suggests the low specificity value of ICD codes for
T1DM (26%) in previous study [34].
Overall, the patients in this study spent more nights in the hospital than was previously
reported among inpatient with (7 vs. 5–6 days) and without (approximately 5 days) diabetes [35,36],
which increases the cost of hospitalization [37,38]. A study found that the cost of hospitalization
was approximately 1.5 times higher in patients who were aged ≥ 60 years than those aged ≤ 40
years. The cost further increases if the patients had any diabetes-related complications [39] and in
the present study, a large proportion of the admitted patients (Figure 4) had a complication which
further indicates the high burden of diabetes in this public hospital. Formal early detection of diabetes
through opportunistic testing in this high-risk age group population will help to reduce the burden of
diabetes by identifying new cases and reduce complications. Past studies [12,25,40] including a recent
study in Blacktown Hospital which identified 32.2% new adult cases of diabetes following a six-week
screening period using HbA1c testing [12] has shown significant benefits of opportunistic testing in
hospitals. In another study, George et al. found 2.6% new cases of diabetes through opportunistic
testing of 500 ED patients without previous diabetes [41] which was similar to the 2.2% found in this
study considering only those who underwent HbA1c testing.
There are some limitations to this study. The study relied on accurate clinical coding for new
diabetes diagnosis, which could have underestimated the number of newly diagnosed diabetes at
the hospital by up to 28%, as was suggested in a previous study [12]. Data for some patients with
diabetes, who attended the ED and discharged on the same day, may not be captured in this study.
The 3 month chart review should have identified all individuals with known diabetes, but in the
absence of testing, the study design restricted the data to participants coded with diabetes in the ED,
making it difficult to find potentially missed cases with diabetes. In addition, other variables may
have been inaccurately coded, and this may affect the reported prevalence of certain diabetes-related
complications and co-morbidities. For example, weight record was inconsistent, and found in different
locations throughout the medical record and frequently omitted in short admissions or those of older
patients. In some cases, the only available measurement was an estimated weight, which when
compared with actual measurements in the patients’ files (where both measurements were available),
often varied greatly. The finger prick blood glucose levels were often, but not always taken at triage,
and the initial reading may not necessarily reflect the patient’s initial blood glucose level on entry to the
hospital. In a number of case histories, a patient may have been described as critically hypoglycaemic
on arrival to the ED but may have been treated by the time a blood glucose test was done, which would
bring the glucose reading within the normal range. The same was true for some patients who arrived
at the ED with extreme hyperglycemia or blood pressure outside the normal range.
5. Conclusions
In summary, there was a low diagnosis rate of diabetes among older adults admitted to the
hospital through the ED in South Western Sydney. The low uptake of HbA1c testing among these
individuals indicate that many individuals aged ≥ 60 years with diabetes remain undiagnosed even
during admission and/or that many are going to the ED with unknown diabetes that is unidentified
with current practices. The clinically important HbA1c result was seldomly communicated to the
GPs, suggesting the need to measure and improve discharge summary quality in this hospital.
Unavailability of such notes in the discharge summary may affect the management plan of patients or
lead to unnecessary test repeats during consultation.
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